NOV 28, 2015 06:44 AM PST

Rare Tropical Disease Puts Transplant Patients At Risk

WRITTEN BY: Kara Marker
Leishmaniasis is an infectious disease caused by the bite of parasite-infected sand flies, and it's usually found in tropical regions and southern Europe. The infection can be either cutaneous, causing skin sores, or visceral, affecting internal organs (CDC). The number of leishmaniasis infections has quadrupled since the 1990s, and researchers from Spain looked to calculate the risk and determine how to prevent infections in vulnerable transplant patients. 
 Geographical distribution of visceral leishmaniasis

In a recent study published in PLoS Neglected Tropical Diseases, scientists looked at 63 individuals who had received solid organ transplants and worked to determine the number of patients who had come into contact with the parasite and what their risk was of developing leishmaniasis at any point for the rest of their lives. Because of the immunosuppressive therapy transplant patients receive to prevent organ rejection, these patients have a 100 times greater risk of developing severe visceral leishmaniasis compared to immunocompetent people.

The team conducted two tests scanning for any form of leishmaniasis infection. One test involved experimental lymphocyte proliferation assays and cytokine production analysis, to examine how the immune system was working, potentially hinting at a leishmaniasis invasion. The second test was more routine - "serologic and parasitology tests" that are normally used to diagnose cases of leishmaniasis. 

The scientists saw a correlation between the two tests, and this initial success points to the experimental assays as new indicators of leishmaniasis progression at various stages of infection. Continuing studies with these analytic tests could help scientists understand the relationship between transplant patients and their lifetime risk of developing leishmaniasis. 

Ultimately, the team is interested in preventing the initial transmission of leishmaniasis as well as relapse recovery. Identifying which immunocompromised patients are at high risk of relapsing with infection could help doctors know when to administer additional chemotherapeutics to prevent additional infections in individuals not completely recovered. 

"Being the recipient of an organ tranplant is increasingly common amoung the Spanish population," said Dr. Javier Moreno, team researcher. "As a consequence, it is necessary to both prevent the risk of infection in transplant patients and to adopt appropriate measures for disease management and prevention in clinical cases in order to prevent relapses."

Watch the following video to learn more about leishmaniasis. 

Source: Plataforma SINC
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 12, 2018
Neuroscience
NOV 12, 2018
Role Of Choroid Plexus Protein Klotho In Aging
Inflammaging, describes the increase in an inflammatory alteration in the brain, due to aging and predicts the morbidity and mortality in older humans....
NOV 13, 2018
Immunology
NOV 13, 2018
Yin & Yang: The Duality of Cancer-Associated Fibroblasts in Pancreatic Cancer
Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United States (1). It is painful and usua...
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
NOV 21, 2018
Immunology
NOV 21, 2018
HIV Persisting How?
A team of researchers have identified an HIV reservoir...
DEC 10, 2018
Health & Medicine
DEC 10, 2018
Sarcoidosis: Severe Infections and Complications
  Sarcoidosis is characterized by an exaggerated immune response to an unrecognized antigen, which has not yet been identified. It is an inflammatory...
DEC 19, 2018
Immunology
DEC 19, 2018
UTI Infection Becoming a Common Reoccurrence?
Researchers have shed new light on the connection between recurring urinary tract infections and the bacterial strain involved...
Loading Comments...